Reboost
- Product NDC
- 62795-1042
- Requested package NDC
- 62795-1042-2
- 11-digit product format
- 627951042
- Labeler code
- 62795
- Product ID
- 62795-1042_da0a425e-b716-4f93-9903-c3db9058abaf
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACONITUM NAPELLUS, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, GOLDENSEAL, LACHESIS MUTA VENOM, PHOSPHORUS, VINCETOXICUM HIRUNDINARIA ROOT, ZINC GLUCONATE, ZINC ACETATE ANHYDROUS, CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE, IPECAC, SULFUR and INFLUENZA A VIRUS A/SINGAPORE/6/86 (H1N1) ANTIGEN (HEAT INACTIVATED)
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- MediNatura Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2020-02-19
- Marketing end
- 2025-04-30
- Substance
- ACONITUM NAPELLUS; BRYONIA ALBA ROOT; EUPATORIUM PERFOLIATUM FLOWERING TOP; LACHESIS MUTA VENOM; GOLDENSEAL; PHOSPHORUS; VINCETOXICUM HIRUNDINARIA ROOT; ZINC GLUCONATE; ZINC ACETATE ANHYDROUS; CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE; IPECAC; SULFUR; INFLUENZA A VIRUS A/SINGAPORE/6/86 (H1N1) ANTIGEN (HEAT INACTIVATED)
- Active strength
- 3 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 62795-1042 | 62795-1042-2 | D | Discontinued by firm | 2026-10-15 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 62795-1042 | 62795-1042-2 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 62795-1042 | 62795-1042-2 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 62795-1042-2 | 62795104202 | 1 BOTTLE in 1 CARTON (62795-1042-2) > 60 TABLET in 1 BOTTLE | 1 bottle | 2020-02-19 | 2025-04-30 | No | No | Current |